Alexander Kapp (dermatologist and allergist)

Last updated
Alexander Kapp
Kapp 04.jpg
Born (1955-02-28) February 28, 1955 (age 69)
Heidelberg, Germany
Known for Pathophysiology of inflammatory skin diseases (atopic dermatitis, psoriasis)
AwardsHerbert-Herxheimer-Advancement Award (1993/96), Herbert-Herxheimer Memorial Award (1999), Erich-Fuchs Award (2013)
Scientific career
FieldsDermatology, allergy
InstitutionsHannover Medical School

Alexander Kapp (born 28 February 1955) is a German dermatologist and allergist. He was chairman and medical director of the department of dermatology and allergy at the Hannover Medical School until his retirement in 2022. He is known for his work in the field of pathophysiology of inflammatory skin diseases (atopic dermatitis, psoriasis), his research on neuro-immunological interactions in allergic inflammation and on the role of eosinophilic granulocytes in allergy and dermatology.

Contents

Biography

Kapp was born in Heidelberg studied human medicine at the University of Heidelberg; Germany, from 1974 to 1980 and qualified in 1980 as medical doctor with his thesis on " T-lymphocyte function in atopic dermatitis". He then spent research fellowships at the University of Heidelberg, the University of Freiburg, and the Max-Planck-Institute of Immunobiology in Freiburg. After the residency in dermatology at the University of Freiburg, he received board certification in dermatology and allergy in 1987. In 1988, he became Associate Professor for Dermatology and Venereology and in 1990 head of the section Allergy and Immunological Diagnostics at the University of Freiburg. Since 1994, he has held the position of professor, chairman and director of the Department of Dermatology and Allergy at the Hannover Medical School. [1] [2]

Scientific contribution

Kapp worked in the field of in vitro diagnostics of allergic diseases. However, his main research interest lies in the pathophysiology of inflammatory skin diseases, particularly atopic dermatitis and psoriasis. [3] [4] [5] His main focus in allergy research is in the field of insect allergies and allergic rhinitis, particularly the specific immunotherapy of these diseases, as well as diagnostic and treatment of urticarial. [6] [7] [8] Genetics, diagnostic and treatment of malignant skin tumours are also in the focus of his scientific work. [9] [10] [11] Kapp participated in the development of national and European guidelines on allergy. [12] [13] He was clinical investigator in various clinical studies as well as study director of national and European clinical multicenter studies in the field of dermatology and allergy as well as conductor and coordinator of various in vitro studies in the field of inflammation research and allergy. [14]

Honors and awards

Related Research Articles

<span class="mw-page-title-main">Allergy</span> Immune system response to a substance that most people tolerate well

Allergies, also known as allergic diseases, are various conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. These diseases include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, coughing, a runny nose, shortness of breath, or swelling. Note that food intolerances and food poisoning are separate conditions.

<span class="mw-page-title-main">Dermatitis</span> Inflammatory disease of the skin

Dermatitis is a term used for different types of skin inflammation, typically characterized by itchiness, redness and a rash. In cases of short duration, there may be small blisters, while in long-term cases the skin may become thickened. The area of skin involved can vary from small to covering the entire body. Dermatitis is also called eczema but the same term is often used for the most common type of skin inflammation, atopic dermatitis.

<span class="mw-page-title-main">Contact dermatitis</span> Inflammation from allergen or irritant exposure

Contact dermatitis is a type of acute or chronic inflammation of the skin caused by exposure to chemical or physical agents. Symptoms of contact dermatitis can include itchy or dry skin, a red rash, bumps, blisters, or swelling. These rashes are not contagious or life-threatening, but can be very uncomfortable.

<span class="mw-page-title-main">Hives</span> Skin disease characterized by red, raised, and itchy bumps

Hives, also known as urticaria, is a kind of skin rash with red and/or flesh-colored, raised, itchy bumps. Hives may burn or sting. The patches of rash may appear on different body parts, with variable duration from minutes to days, and do not leave any long-lasting skin change. Fewer than 5% of cases last for more than six weeks. The condition frequently recurs.

<span class="mw-page-title-main">Omalizumab</span> Monoclonal antibody medication

Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria (hives), and immunoglobulin E-mediated food allergy.

<span class="mw-page-title-main">Atopy</span> Predisposition towards allergy

Atopy is the tendency to produce an exaggerated immunoglobulin E (IgE) immune response to otherwise harmless substances in the environment. Allergic diseases are clinical manifestations of such inappropriate, atopic responses.

<span class="mw-page-title-main">Atopic dermatitis</span> Long-term form of skin inflammation

Atopic dermatitis (AD), also known as atopic eczema, is a long-term type of inflammation of the skin. Atopic dermatitis is also often called simply eczema but the same term is also used to refer to dermatitis, the larger group of skin conditions. Atopic dermatitis results in itchy, red, swollen, and cracked skin. Clear fluid may come from the affected areas, which can thicken over time.

Photodermatoses is a skin condition resulting in abnormal skin reactions to ultraviolet (UV) radiation. These abnormal skin reactions may develop into rashes. While reactions to UV radiation is common, true photodermatoses is considered when an abnormal reaction is caused by UV-A rays or radiation between 320 and 400 nm.

<span class="mw-page-title-main">Prurigo nodularis</span> Medical condition

Prurigo nodularis (PN), also known as nodular prurigo, is a skin disorder characterized by pruritic (itchy), nodular lesions, which commonly appear on the trunk, arms and legs. Patients often present with multiple excoriated nodules caused by chronic scratching. Although the exact cause of PN is unknown, PN is associated with other dermatologic conditions such as untreated or severe atopic dermatitis and systemic causes of pruritus including liver disease and end stage kidney disease. The goal of treatment in PN is to decrease itching. PN is also known as Hyde prurigo nodularis, or Picker's nodules.

<span class="mw-page-title-main">CCL17</span> Mammalian protein found in Homo sapiens

CCL17 is a powerful chemokine produced in the thymus and by antigen-presenting cells like dendritic cells, macrophages, and monocytes. CCL17 plays a complex role in cancer. It attracts T-regulatory cells allowing for some cancers to evade an immune response. However, in other cancers, such as melanoma, an increase in CCL17 is linked to an improved outcome. CCL17 has also been linked to autoimmune and allergic diseases.

Aquagenic urticaria, also known as water allergy and water urticaria, is a form of physical urticaria in which hives develop on the skin after contact with water, regardless of its temperature. The condition typically results from contact with water of any type, temperature or additive.

Id reactions are types of acute dermatitis developing after days or weeks at skin locations distant from the initial inflammatory or infectious site. They can be localised or generalised. This is also known as an autoeczematous response and there must be an identifiable initial inflammatory or infectious skin problem which leads to the generalised eczema. Often intensely itchy, the red papules and pustules can also be associated with blisters and scales and are always remote from the primary lesion. It is most commonly a blistering rash with itchy vesicles on the sides of fingers and feet as a reaction to fungal infection on the feet, athlete's foot. Stasis dermatitis, allergic contact dermatitis, acute irritant contact eczema and infective dermatitis have been documented as possible triggers, but the exact cause and mechanism is not fully understood. Several other types of id reactions exist including erythema nodosum, erythema multiforme, Sweet's syndrome and urticaria.

One of the most prevalent forms of adverse drug reactions is cutaneous reactions, with drug-induced urticaria ranking as the second most common type, preceded by drug-induced exanthems. Urticaria, commonly known as hives, manifests as weals, itching, burning, redness, swelling, and angioedema—a rapid swelling of lower skin layers, often more painful than pruritic. These symptoms may occur concurrently, successively, or independently. Typically, when a drug triggers urticaria, symptoms manifest within 24 hours of ingestion, aiding in the identification of the causative agent. Urticaria symptoms usually subside within 1–24 hours, while angioedema may take up to 72 hours to resolve completely.

<span class="mw-page-title-main">Pressure urticaria</span> Medical condition

Pressure urticaria or delayed pressure urticaria is a physical urticaria caused by pressure applied to the skin, and is characterized by the development of swelling and pain that usually occurs 3 to 12 hours after local pressure has been applied.

Torsten Zuberbier is a German dermatologist and allergologist.

<span class="mw-page-title-main">Nickel allergy</span> Medical condition

Nickel allergy is any of several allergic conditions provoked by exposure to the chemical element nickel. Nickel allergy often takes the form of nickel allergic contact dermatitis (Ni-ACD), a form of allergic contact dermatitis (ACD). Ni-ACD typically causes a rash that is red and itchy and that may be bumpy or scaly. The main treatment for it is avoiding contact with nickel-releasing metals, such as inexpensive jewelry. Another form of nickel allergy is a systemic form: systemic nickel allergy syndrome (SNAS) can mimic some of the symptoms of irritable bowel syndrome (IBS) and also has a dermatologic component.

<span class="mw-page-title-main">C-C motif chemokine ligand 27</span> Mammalian protein found in Homo sapiens

C-C motif chemokine ligand 27 is a protein that in humans is encoded by the CCL27 gene.

<span class="mw-page-title-main">Autoimmune urticaria</span> Autoimmune disease causing hives and itching

Autoimmune urticaria, also known as chronic autoimmune urticaria, is a type of chronic urticaria characterized by the presence of autoantibodies in the patient's immune system that target the body's own mast cells, leading to episodes of hives (urticaria). This immunologically distinct type of urticaria is considered autoimmune because the immune system, which normally protects the body from foreign organisms, mistakenly attacks the body's own cells, causing inflammation and other symptoms.

Carsten Flohr was born in Hannover, Germany. He attended the Matthias-Claudius Gymnasium Gehrden, where he won the prestigious Studienstiftung des deutschen Volkes prize, awarded to the top 1% of German secondary school graduates. Following a gap year in Taipei and Shanghai, Carsten Flohr co-enrolled in Medicine and Chinese Studies at Göttingen University, Germany, where he completed his pre-clinical studies with a distinction in 1993 and also later graduated with an MA in Chinese Studies (2000). Carsten Flohr then moved to Trinity College at Cambridge University to undertake a Master of Philosophy in the History of Medicine (1995), before moving to Balliol College at Oxford University to complete his clinical medical studies (1995–1998). He then trained in general medicine, paediatrics and dermatology in Oxford, Newcastle and Nottingham between 1998 and 2003, before being awarded the John Radcliffe Senior Research Fellowship from University College Oxford. This took him to study the links between helminth parasites and allergic disease at the Oxford University Clinical Research Unit in Vietnam (2004–2007), showing that gut parasites protect against allergic disease, one important reason why allergies are now so common in affluent country settings. While in Vietnam, Flohr also undertook a Masters of Science in Epidemiology at the London School of Hygiene & Tropical Medicine.

References

  1. Merk HF, Krutmann J: Laudatio zum 65. Geburtstag von Herrn Prof. Dr. Alexander Kapp. Hautarzt 71:917-918 (2020)
  2. Czech W, Wedi B, Werfel Th: 65. Geburtstag von Prof. Dr. Alexander Kapp: Immer im Einatz für Dermatologie und Allergologie. Allergo J 29:62-63 (2020)
  3. Raap U, Kapp A: Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol 5:419-424, 2005
  4. Werfel T, Kapp A: Chapter 7: Atopic dermatitis and allergic contact dermatitis. In: Holgate S, Church M, Lichtenstein L (eds): Allergy: Third Edition. Mosby/Elsevier, London, U.K., pp 107–127, 2006
  5. Werfel T, Schwerk N, Hansen G, Kapp A: The Diagnosis and Graded. Therapy of Atopic Dermatitis. Dtsch Ärztebl Int 111:509-520 (2014)
  6. Wedi B, Kapp A: Angio-oedema and urticaria. In: Custovic A, Platts-Mills TAE (eds) Managing Allergy. Clinical Publ, Oxford, pp 111–128, 2009
  7. Wedi B, Kapp A: Urticaria and Angioedema. In: Mahmoudi M (ed) Allergy & Asthma – Practical diagnosis and management. Mc Graw Hill - Lange, New York, pp 84–94, 2007
  8. Wedi B, Wieczorek D, Raap U, Kapp A: Urticaria. JDDG 12:997-1010 (2014)
  9. Weiß J, Herbst RA, Kapp A: Genetics of cutaneous malignant melanoma. Onkologie 22:478-484 (1999)
  10. Gutzmer R, Wollenberg A, Ugurel S, Homey B, Ganser A, Kapp A: Cutaneous Side Effects of New Antitumor Drugs: Clinical Features and Management. Dtsch Ärztebl Int 109:133-140 (2012)
  11. Alter M, Satzger I, Mattern A, Kapp A, Gutzmer R: Treatment of Advanced Cutaneous Squameous Cell Carcinomas with Epidermal Growth Factor Receptor Inhibitors. Dermatology 227:289-294 (2013) 10
  12. https://register.awmf.org/de/start
  13. https://hub.eaaci.org/resources/guidelines/
  14. https://www.researchgate.net/profile/Alexander-Kapp
  15. Deutscher Ärzte-Verlag GmbH, Redaktion Deutsches Ärzteblatt (11 April 1997). "Deutsches Ärzteblatt: Verleihungen (11.04.1997)". aerzteblatt.de.
  16. Alexander Kapp receives Erich-Fuchs award